Flavored Tobacco Products Linked to Future Tobacco Use in Youth and Adults
The use of flavored tobacco products has been associated with tobacco experimentation among youth and young adults.
Home
New Cheek Swab Helps Rule Out Genetic Form of COPD
A new cheek swab, known as AlphaID (Grifols), has been made available for physicians to screen patients with chronic obstructive pulmonary disease (COPD) for alpha-1 antitrypsin deficiency (Alpha-1).
Acute RTI Lab Testing More Likely in Children Without Up-to-Date Vaccinations
Children hospitalized with acute respiratory tract illness without up-to-date vaccinations had higher odds of receiving laboratory testing compared with children whose status was up to date.
San Francisco Vaping Ban Upheld by Voters
Tuesday’s vote makes San Francisco the first major US city to ban all e-cigarette sales.
Stephen Hahn, MD Nominated to Head FDA
Dr Hahn is chief medical executive of The University of Texas MD Anderson Cancer Center in Houston.
Benralizumab Improved Total Nasal Symptom Score in Severe Asthma
Among patients with severe asthma, benralizumab treatment improved nasal symptoms, which worsen with increasing baseline blood eosinophil count.
Mepolizumab Significantly Reduces Asthma Exacerbations and Associated Costs
In a real-world setting, mepolizumab therapy significantly reduced the rate of asthma exacerbations and their related costs.
Family History of Cancer: A Significant Risk Factor for Childhood Asthma?
Children with a family history of cancer may be more likely to develop childhood asthma.
Ragweed SLIT Tablet Improves Symptoms in Children With Ragweed Allergic Rhinitis
Ragweed sublingual immunotherapy tablet improved symptoms and decreased the need for rescue medication in the largest allergy immunotherapy trial in children with ragweed allergic rhinitis with or without conjunctivitis.
High-Dose Peanut Oral Immunotherapy Safe, Effective for Peanut Allergy
High-dose peanut oral immunotherapy provided similar or greater efficacy than other previously reported forms of peanut oral immunotherapy without additional safety concerns.
Want to read more?
Please login or register first to view this content.
Next post in ACAAI 2019
